Flow cytometry has emerged as a critical analytical tool in clinical research, particularly in therapeutic areas such as autoimmunity, oncology, and infectious diseases. Its ability to provide multiparametric analysis at single-cell resolution, combined with high-throughput capabilities, makes it invaluable for understanding cellular dynamics. However, a significant challenge arises in multi-center clinical trials, where variability in instrument settings, reagents, and operator techniques across laboratories can compromise data consistency.
The complexity of achieving standardized data across globally distributed sites represents a major logistical and scientific challenge for drug developers. Discrepancies in flow cytometry readouts can lead to delays, increased costs, and the need for additional testing, ultimately hindering the reliability and reproducibility of results.
To address these challenges, we developed a novel, cost-efficient method for aligning flow cytometry instruments across five laboratories. The approach involved the use of polystyrene microbeads (BD™ CompBeads) pre-stained with CD4 antibodies and lyophilized to ensure stability at room temperature for up to 18 months. These beads were then distributed to five sites for calibration, resulting in consistent instrument performance across all locations. This harmonization process effectively created a unified ‘fleet’ of instruments, enabling comparable data collection.
The stability of the lyophilized beads after resuspension was evaluated at multiple time points, with mean fluorescence intensity (MFI) readings taken at 15 minutes, 30 minutes, and up to 48 hours post-resuspension. The results demonstrated that most fluorochromes remained stable, though certain dyes required replacement to improve long-term stability. The updated kit, incorporating more robust alternatives such as RB705, Alexa-647, and Alexa Fluor®-700, provided consistent signal acquisition for up to 8 hours post-resuspension.
To confirm the assay’s alignment across sites, we aligned nine fluorescence parameters using the lyophilized beads and evaluated assay reproducibility. Readouts from the participating laboratories showed a coefficient of variation below 25% compared to the reference laboratory, with many falling below 10%. This level of consistency confirmed successful assay alignment, enabling reliable cross-site data comparison.
The study demonstrated that pre-stained, lyophilized beads offer a practical solution for multi-site instrument alignment in flow cytometry. Key benefits include:
– Maintained data quality and reliability: Beads remain effective for up to 48 hours post-resuspension and exhibit consistent performance even after a year.
– Consistency across sites: Instrument and assay harmonization reduces variability, facilitating accurate cross-location data comparisons.
– Cost and time savings: The 18-month stability of the beads minimizes shipping and recalibration needs, streamlining workflows and reducing costs.
This method enhances the reliability and cost-effectiveness of flow cytometry in global clinical trials, supporting high-quality, consistent clinical research.
